
Weir pointed out that significant benefits were seen with concurrent SGLT2 inhibitor use.

Matthew R. Weir, MD is an attending physician and Director of the Division of Nephrology in the Department of Medicine at the University of Maryland Hospital.

Weir pointed out that significant benefits were seen with concurrent SGLT2 inhibitor use.

With so many new medications ostensibly filling the niche typically occupied by ACE/ARBs, are the medications practically useful in a changed treatment landscape?

Matthew Weir, MD discusses how a multidisciplinary approach is reshaping CKD management, with a focus on mitigating cardiovascular events.